Navigation Links
Regeneron Announces September 2009 Investment Conference Presentations

TARRYTOWN, N.Y., Sept. 10 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations that are scheduled for delivery later this month at the following investment conferences:

  • The Morgan Stanley Global Healthcare Unplugged Conference at 8:00 a.m. Eastern Time on Tuesday, September 15
  • The NewsMakers in the Biotech Industry Conference at 9:00 a.m. Eastern Time on Wednesday, September 16
  • The ThinkEquity Annual Growth Conference at 2:00 p.m. Eastern Time on Thursday, September 17
  • The UBS Global Life Sciences Conference at 9:00 a.m. Eastern Time on Monday, September 21

The presentation at the Morgan Stanley Global Healthcare Unplugged Conference will be a conversation with Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron, and a Morgan Stanley analyst. The presentations at the other conferences will provide an overview of the Company, including its three Phase 3 clinical programs.

The sessions may be accessed through the Company's web site,, on the Investor Relations page under the Presentations heading. Archived versions of the presentations will be available for thirty days after the live webcasts. Additional information about Regeneron and recent news releases are available on the Regeneron web site.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST(R) (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain, and has preclinical programs in other diseases and disorders.

    Contact Information:
    Peter Dworkin                   Laura Lindsay
    Investor Relations              Media Relations
    914.345.7640                    914.345.7800

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Amedica Announces New Global Headquarters
2. Major Rollback of Pharmaceutical Bench Mark Prices Approved by Federal Court of Appeals, Hagens Berman Announces
3. TEDIndia Announces List of Inspiring Speakers from Across the Globe
4. Inverness Medical Innovations Announces September Investor Conference Schedule
5. JHD Group Announces TURNKEY EHR(TM) Service
6. SXC Health Solutions announces PBM contract renewal with Hawaii Employer-Union Health Benefits Trust Fund
7. VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform
8. Patriot Scientific Corporation Announces Alcon Inc.s Purchase of a Moore Microprocessor Patent(TM) Portfolio License
9. QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena(TM) (Ospemifene Tablets) in Treatment of Postmenopausal Vaginal Atrophy
10. NBTY To Web Cast Presentation at CL King Best Ideas Conference; Announces Preliminary Unaudited Net Sales Results For August 2009
11. Sambazon Announces Scientific Advisory Board
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Physicians’ Education Resource®, LLC ... today announced that the first annual School of Gastrointestinal Oncology™ (SOGO™) will be ... and treatment of gastrointestinal cancers are undergoing transformational change, providing oncologists with powerful ...
(Date:12/1/2015)... ... 2015 , ... Growth in medical payments per workers’ compensation claim in Louisiana ... and nonhospital care, according to a recent study by the Workers Compensation Research Institute ... found medical payments per claim with more than seven days of lost time continued ...
(Date:12/1/2015)... Illinois (PRWEB) , ... December 01, 2015 , ... ... and share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ ... Society of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. ... results enhancements at the Radiological Society of North America (RSNA) 2015 annual meeting ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... solutions for the care management and population health arenas, is pleased to announce ... and cost containment services, has successfully implemented the ACUITY Complete Care™ Management to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Germany , December 1, 2015 /PRNewswire/ ... leading global manufacturer of eye and gaze tracking solutions, ... SMI remote eye trackers as a component of its ... concussions, eye sight, and medical and performance issues in ... part of SMI,s mass-market-ready eye tracking platform, which is ...
(Date:12/1/2015)... 1, 2015 --> ... van Leeuwenhoek Hospital (NKI-AVL), among the world,s largest ... Leksell Gamma Knife® Icon™, the company,s latest generation ... --> --> With the ... treatments, Leksell Gamma Knife Icon offers greatly enhanced ...
(Date:12/1/2015)... Dec. 01, 2015 ... "Drug Delivery Technology Market 2015 - Forecast ... --> ) has announced the addition ... - Forecast to 2020" report to their ... ) has announced the addition of the ...
Breaking Medicine Technology: